What the tirzepatide logo actually signals — and why it matters

You're holding a pen and wondering if it's the real thing

Picture this: a box arrives, a logo printed cleanly on the side, a KwikPen inside with what looks like the right branding. The question a lot of people don't think to ask until that moment is: how do I know this is genuine?

Tirzepatide is the molecule. Mounjaro is the trademarked name Eli Lilly uses for it in the UK, and the Mounjaro logo (its typeface, colour and pen markings) is a regulated part of that product's identity. The pen itself is a pre-filled KwikPen, available in six doses (2.5, 5, 7.5, 10, 12.5 and 15 mg). Each strength has its own colour-coded label. Legitimate packaging includes a batch number, expiry date, storage instructions and the Black Triangle (▼) symbol, which the MHRA requires for medicines under additional monitoring. That triangle is not a warning of danger; it signals that the regulator is collecting extra data on the product.

A common misconception is that the Black Triangle means a medicine is experimental or less safe than others. It doesn't. It's a transparency measure, and tirzepatide carries it because it's relatively new to the UK market. The NHS medicines page for tirzepatide explains what the symbol means in plain terms.

If any of those packaging elements are missing (no batch number, no triangle, no UK-licensed importer details) treat it as a serious red flag.

Why the logo question matters more than it might seem

When people search for the tirzepatide logo, they're often trying to verify something: a seller's legitimacy, the authenticity of their own supply, or simply satisfying curiosity before they commit to treatment. All three are reasonable, and the answer to each is similar, the logo is useful, but it's not the whole story.

The MHRA has publicly confirmed that counterfeit tirzepatide pens are circulating in the UK. Fake packaging can reproduce logos convincingly; some counterfeit pens have contained the wrong substance entirely. The enforcement response has been significant, around 20 million doses of illegally traded weight-loss medicines (roughly £45 million street value) were seized in 2025 alone, including the first UK site producing fake tirzepatide pens, raided in Northampton in October 2025. Logos on those pens looked right. The supply chain did not.

The only safeguard that actually holds up is sourcing your medicine through a pharmacy you can verify. The GPhC maintains a public register of every legitimately operating UK pharmacy at pharmacyregulation.org/registers. Checking a pharmacy there takes about thirty seconds and tells you whether it's registered and in good standing. For context on how private pricing compares across providers, the Mounjaro prices page sets out what the market typically looks like and what a legitimate price should include.

Tirzepatide versus Mounjaro: same medicine, different labels

If you've seen the word tirzepatide on some packaging and Mounjaro on other packaging and assumed they're different products, you're not alone. They're not different, tirzepatide is the generic scientific name, required to appear on all UK-licensed products; Mounjaro is Eli Lilly's brand. For a fuller explanation of the relationship between the two names, the Mounjaro or tirzepatide page covers it in detail.

The practical effect is that when you receive a legitimate prescription, the pen you're dispensed will say Mounjaro. The prescription itself, the clinical notes and NHS documentation may say tirzepatide. Both refer to exactly the same molecule, the same clinical evidence and the same licensing. NICE appraised tirzepatide under TA1026 (published December 2024, updated September 2025), it recommends it for adults with a BMI of 35 or above alongside at least one weight-related condition, with lower BMI thresholds for some ethnic backgrounds. Private prescribing follows the SmPC's broader eligibility criteria, which a prescriber applies to your specific circumstances.

Tirzepatide is a prescription-only medicine; a prescriber assesses suitability before any supply. To understand what that assessment involves and what the treatment looks like in practice, including details specific to the tirzepatide l strength, the tirzepatide overview page is the logical next step.

Checking legitimacy before you start

The logo question often surfaces at the same moment someone is weighing up whether to go ahead with treatment. That's a healthy instinct. A genuine, regulated supply means the pen contains what it says, at the concentration stated, manufactured to pharmaceutical standards.

Before starting, confirm: the pharmacy is on the GPhC register; your consultation involves a real clinician reviewing your answers, not an automated decision; and your pen arrives in intact, fully labelled packaging with batch number and expiry intact. At our pharmacy, every order is reviewed by a GPhC-registered Independent Prescriber before any supply is made. The pen ships the same day if approved before 12pm, via tracked DPD, in plain packaging.

If you have specific questions about the process or something on your packaging doesn't look right, the contact page connects you to the team directly. Our FAQs also cover what to expect at each stage, from consultation through to delivery.

When you're ready to have your eligibility assessed by a prescriber, start your free consultation here.